Silver Book Fact

Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.

Dellapina E, Ory- Magne F, Regragui W, et al. Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease. Pain. 2012; 153(11): 2267-73. http://www.painjournalonline.com/article/S0304-3959(12)00453-8/abstract

Reference

Title
Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Publication
Pain
Publication Date
2012
Authors
Dellapina E, Ory- Magne F, Regragui W, et al
Volume & Issue
Volume 153, Issue 11
Pages
2267-73
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • Pain education programs and pain consultations have been found to improve pain (average pain was 31% versus 20%) and daily interference (20% versus 2.5%) in oncology outpatients. Patient adherence…